Humira (adalimumab)

pCPA File Number: 20922

Negotiation Status:

Concluded with an LOI

Indication(s):

Ulcerative Colitis

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

SR0450-000

pCPA Engagement Letter Issued:

2016-05-31

Negotiation Process Concluded:

2017-05-23